TY - JOUR
T1 - Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying After Esophagectomy
T2 - Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying after Esophagectomy
AU - Feenstra, Minke L.
AU - Alkemade, Lily
AU - van den Bergh, Janneke E.
AU - Gisbertz, Suzanne S.
AU - Daams, Freek
AU - van Berge Henegouwen, Mark I.
AU - Eshuis, Wietse J.
N1 - Funding Information: We thank Songül Küçükçelebi for her efforts contributing to this study, especially for collecting the high volume of data. Publisher Copyright: © 2022, The Author(s).
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Background: Nasogastric tube (NGT) insertion is the standard of care in many hospitals after esophagectomy for gastric conduit decompression. An upper gastrointestinal contrast passage evaluation (UGI-CE) is a diagnostic test to evaluate passage through the gastric conduit. The authors hypothesized that introducing routine UGI-CE after esophagectomy results in earlier removal of the NGT and resumption of oral intake. Methods: This retrospective study evaluated two consecutive series of patients undergoing esophagectomy, one before (control group) and one after the introduction of a routine UGI-CE on postoperative day (POD) 3 or 4 (UGI-CE group). If contrast passage was found on the UGI-CE, the NGT was capped and removed. In the control group, the NGT was routinely capped and removed on day 5 after surgery. The primary outcome was the POD on which oral diet was initiated. The secondary outcomes were the day of NGT removal, NGT reinsertions, postoperative complications, and length of hospital stay. Results: Each cohort included 74 patients. In the UGI-CE group, the contrast test was performed on median POD 3.5 (IQR, 3–4). The median day of NGT removal, initiation of clear liquids, and full liquid and solid intake was 1 to 2 days earlier in the UGI-CE group than in the control group (i.e. POD 4, 4, 5, and 6 vs. POD 5, 5, 6.5, and 8; all p < 0.001). The study found no significant differences in NGT reinsertions, pneumonias, anastomotic leakages, or hospital stay. Conclusion: The routine use of a UGI-CE after esophagectomy led to earlier removal of the NGT and earlier resumption of oral intake.
AB - Background: Nasogastric tube (NGT) insertion is the standard of care in many hospitals after esophagectomy for gastric conduit decompression. An upper gastrointestinal contrast passage evaluation (UGI-CE) is a diagnostic test to evaluate passage through the gastric conduit. The authors hypothesized that introducing routine UGI-CE after esophagectomy results in earlier removal of the NGT and resumption of oral intake. Methods: This retrospective study evaluated two consecutive series of patients undergoing esophagectomy, one before (control group) and one after the introduction of a routine UGI-CE on postoperative day (POD) 3 or 4 (UGI-CE group). If contrast passage was found on the UGI-CE, the NGT was capped and removed. In the control group, the NGT was routinely capped and removed on day 5 after surgery. The primary outcome was the POD on which oral diet was initiated. The secondary outcomes were the day of NGT removal, NGT reinsertions, postoperative complications, and length of hospital stay. Results: Each cohort included 74 patients. In the UGI-CE group, the contrast test was performed on median POD 3.5 (IQR, 3–4). The median day of NGT removal, initiation of clear liquids, and full liquid and solid intake was 1 to 2 days earlier in the UGI-CE group than in the control group (i.e. POD 4, 4, 5, and 6 vs. POD 5, 5, 6.5, and 8; all p < 0.001). The study found no significant differences in NGT reinsertions, pneumonias, anastomotic leakages, or hospital stay. Conclusion: The routine use of a UGI-CE after esophagectomy led to earlier removal of the NGT and earlier resumption of oral intake.
UR - http://www.scopus.com/inward/record.url?scp=85139489652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/record.url?scp=85143644532&partnerID=8YFLogxK
U2 - https://doi.org/10.1245/s10434-022-12596-9
DO - https://doi.org/10.1245/s10434-022-12596-9
M3 - Article
C2 - 36210402
SN - 1068-9265
VL - 30
SP - 563
EP - 570
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 1
ER -